SDC1 and urinary bladder carcinoma: In addition, Szarvas et al. [115] used immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) to analyze the tissue expression level and serum concentrations of syndecan-1 (SDC1) in bladder cancer (BC) patients.